510(k) Report

510(k) · Cleared

Cleared

Elecsys Cortisol Test System

K021218510(k) TraditionalCleared Sep 9, 2002145-day reviewClass II21 CFR 862.1205

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics Corp. · JFT Fluorometric, Cortisol

Cleared on Sep 9, 2002 as substantially equivalent to K962559 (Ciba Corning Diagnostics Corp., 1996) after a 145-day review. Its family tree reaches back 1 generation to 1996.

Decided
Sep 9, 2002
Review
145 days
Class
Class II
Product code
JFT
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K962559 (1996). No later device cites it as a predicate yet.

K962559 · Acs Cortisol Immunoassay · Ciba Corning Diagnostics Corp. · 1996 · recalled19961998200020022004
  1. Root · 1 generation backK962559 Acs Cortisol ImmunoassayCiba Corning Diagnostics Corp. · 1996 · Recalled
  2. This deviceK021218 Elecsys Cortisol Test SystemRoche Diagnostics Corp. · 2002
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K962559Acs Cortisol ImmunoassayCiba Corning Diagnostics Corp.19962
0 (this device)K021218Elecsys Cortisol Test SystemRoche Diagnostics Corp.2002—
FIG. 1 — Lineage of K021218, 1996–2002Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JFT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JFT device

  1. #1 K242505 Elecsys Cortisol IIIscore 10.0 · 2 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K962559Acs Cortisol Immunoassay
Summary page 2
…uivalent to other devices legally marketed in equivalence the United States. We claim equivalence to the Bayer Diagnostics ACS: 180 Cortisol Assay (K962559). 29 510(k) Summary -…
Ciba Corning Diagnostics Corp.19962

Also cleared against K962559: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • 1 other device also cites its predicate K962559.

How does its category compare?

All JFT devices

JFT Fluorometric, Cortisol: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JFT

1in 2025

2015: 12016: 12019: 12025: 1
2007high 1 (2015) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JFT

Too few JFT 510(k)s in any year since 2007 to give a median.

Recalls per year · JFT

1in 2012

2012: 1
2007high 1 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JFT

9in 2025

2011: 12012: 162013: 62016: 22017: 42018: 32019: 62020: 42021: 22022: 22023: 92024: 52025: 9
2007high 16 (2012) · low 0 (2007)2025

MAUDE reports naming product code JFT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—01
20120—116
20130—06
20140—00
20151—00
20161—02
20170—04
20180—03
20191—06
20200—04
20210—02
20220—02
20230—09
20240—05
20251—09
20260—0—

What is it indicated for?

Immunological in vitro assay for the quantitative determination of cortisol in human serum, plasma and urine. The determination of cortisol is used for the recognition and treatment of functional disorders of the adrenal gland.

The electrochemiluminescence immunoassay “ECLIA” is intended for use on the Roche Elecsys® 1010 / 2010 and Modular Analytics E 170 (Elecsys module) Immunoassay Analyzers.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K021218: Elecsys Cortisol Test System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K021218

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026